Walleye Capital
GOSS icon

Walleye Capital’s Gossamer Bio GOSS Stock Holding History

Walleye Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,463
Closed -$3.34M – 4626
2025
Q4 		$3.34M Buy
13,463
+6,642
+97% +$1.52M 0.01% 1459
2025
Q3 		$1.44M Buy
+6,821
New +$1.2M 0.01% 1819
2023
Q2 		– Sell
-20,159
Closed -$2.03M – 4521
2023
Q1 		$2.03M Buy
20,159
+19,931
+8,742% +$3.05M 0.03% 714
2022
Q4 		$39.6K Buy
+228
New +$150K ﹤0.01% 2572
2022
Q3 		– Sell
-6,967
Closed -$6.92M – 3346
2022
Q2 		$4.66M Buy
6,967
+3,807
+120% +$2.36M 0.13% 187
2022
Q1 		$2.2M Buy
3,160
+890
+39% +$687K 0.06% 345
2021
Q4 		$2.05M Buy
+2,270
New +$2.16M 0.06% 321
2021
Q2 		– Sell
-338
Closed -$250K – 1407
2021
Q1 		$250K Buy
+338
New +$273K 0.01% 841
2020
Q2 		– Sell
-45
Closed -$37K – 758
2020
Q1 		$37K Buy
+45
New +$47K 0.01% 716

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Samsara BioCapital
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Walleye Capital's GOSS Position: Q1 2026 in Review

Walleye Capital sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 13,463 shares — an estimated $3.34M sold.

Walleye Capital first reported a position in GOSS in Q1 2020 and held it in 9 quarters. The position peaked at $4.66M in Q2 2022. 181 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Walleye Capital reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 13,463 Gossamer Bio shares in Q1 2026, an estimated $3.34M.
  • Walleye Capital first reported a position in Gossamer Bio in Q1 2020 and held it in 9 quarters.
  • Walleye Capital's Gossamer Bio position peaked at $4.66M in Q2 2022.
  • 181 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.